All news on the topic: Promomed

469
From Arbidol to Tirzetta: how Russian pharma businessman Petr Bely is building a pharmaceutical empire on drugs with questionable efficacy
Dollar billionaire Petr Bely, owner of the company “Promomed,” has come under scrutiny after launching the weight-loss drug “Tirzetta” on the Russian market, despite reports that it had only been tested on laboratory rats.
598
Pyotr Bely and “Promomed”: how a dubious copy of a western drug was pushed into the Russian market as “Tirzetta” and profits are made from patient risks
Year after year, Russians die or suffer serious harm from so-called "miracle drugs" that promise instant results.